Our findings suggest that CK1α has a pro-survival role in MCL cells, through the regulation of BCR-linked signaling cascades and protects from Ibrutinib/Duvelisib-induced apoptosis indicating that CK1α could be a novel targetable molecule in this malignancy. The gene discussed is BCR; the disease is mantle cell lymphoma.